STARR KEVIN P 4
4 · Sage Therapeutics, Inc. · Filed Apr 19, 2018
Insider Transaction Report
Form 4
STARR KEVIN P
Director10% Owner
Transactions
- Sale
Common Stock
2018-04-18$168.28/sh−24,000$4,038,650→ 302,817 total - Sale
Common Stock
2018-04-17$169.25/sh−35,000$5,923,600→ 326,817 total
Holdings
- 37,362(indirect: See Footnote)
Common Stock
Footnotes (1)
- [F1]These shares are directly held by Third Rock Ventures II, L.P. ("TRV II"). The general partner of TRV II is Third Rock Ventures GP II, L.P. ("TRV GP II"). The general partner of TRV GP II is TRV GP II, LLC ("TRV GP II LLC"). The individual managers of TRV GP II LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.